Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) EBT Margin (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed EBT Margin for 15 consecutive years, with 0.2% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 83.0% year-over-year to 0.2%, compared with a TTM value of 4.42% through Oct 2025, up 352.0%, and an annual FY2025 reading of 1.05%, up 690.0% over the prior year.
  • EBT Margin was 0.2% for Q4 2025 at Pharma-Bio Serv, up from 15.99% in the prior quarter.
  • Across five years, EBT Margin topped out at 46.38% in Q3 2021 and bottomed at 85.7% in Q4 2021.
  • Average EBT Margin over 5 years is 0.92%, with a median of 2.69% recorded in 2022.
  • The sharpest move saw EBT Margin crashed -8873bps in 2021, then soared 9068bps in 2022.
  • Year by year, EBT Margin stood at 85.7% in 2021, then soared by 106bps to 4.98% in 2022, then tumbled by -129bps to 1.44% in 2023, then skyrocketed by 56bps to 0.64% in 2024, then surged by 131bps to 0.2% in 2025.
  • Business Quant data shows EBT Margin for PBSV at 0.2% in Q4 2025, 15.99% in Q3 2025, and 4.07% in Q2 2025.